![SELECTBIO SELECTBIO](../images/siteimages/SelectBiosciencesLogo.png)
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic CancerMonday, 14 October 2019 at 14:30 ![]() New approaches to prioritize treatment strategies are urgently needed to improve survival and quality of life for pancreatic cancer patients. Combined genomic, transcriptomic, and therapeutic profiling of patient-derived organoids can identify molecular and functional subtypes of pancreatic cancer, predict therapeutic responses and facilitate precision medicine for pancreatic cancer patients. |